Ion Channels — Comprehensive Study Notes Summary & Study Notes

📌 Overview

These notes summarize key concepts about ion channels, their structure, function, gating, classification and pharmacology with emphasis on excitable cells. Focus on the ions $Na^+$, $K^+$, $Ca^{2+}$ and $Cl^-$ and how channels enable rapid, selective ionic flux across membranes.

🧩 What is an ion channel?

An ion channel is a transmembrane pore-forming protein that allows the passage of charged particles across the lipid bilayer. Channels provide a hydrophilic pathway for ions that cannot cross the membrane unaided due to the hydrophobic core of the bilayer.

⚖️ Key features

• High transport rate: Ion flow through channels can approach rates similar to diffusion in solution.
• Electrochemical driving force: Ions pass down their concentration and electrical gradients.
• Selectivity: Channels are often selective for cations or anions and may prefer specific species (e.g. $K^+$ over $Na^+$).

🔬 Selectivity filter

The selectivity filter is the narrowest region of the pore and determines ion specificity by pore size and lining chemistry. Example: the bacterial KcsA channel has a TVGYG motif forming multiple coordinated binding sites where $K^+$ is chelated by backbone oxygens.

🔐 Gating mechanisms

Gating refers to conformational changes that open or close channels. Common gating mechanisms include:

• Voltage-gated: respond to changes in membrane potential (e.g. Nav, Kv, Cav).
• Ligand-gated (ionotropic): opened directly by ligand binding (e.g. nicotinic acetylcholine receptor).
• Receptor-operated / metabotropic: opened by second messenger pathways downstream of other receptors (e.g. many TRP channels).

Channels can occupy resting (closed), activated (open) and inactivated states; inactivation often involves an intracellular occluding element.

⚡ Ion channels in excitable cells

Excitable cells (neurons, muscle, endocrine secretory cells) use channels to generate action potentials and rapid signaling. Depolarisation often involves increased permeability to $Na^+$ or increased intracellular $Ca^{2+}$ from influx or release from intracellular stores (ER/SR).

Ion gradients (high extracellular $Na^+$ and high intracellular $K^+$) are maintained by pumps such as the Na^+/K^+ ATPase; channels allow rapid, regulated changes in ion distribution during signaling.

🧬 Molecular diversity & classification

Ion channels can be classified by: molecular architecture (number of transmembrane domains e.g. 2TM, 4TM, 6TM), gating mechanism (voltage, ligand, second messenger), ion selectivity (K+, Na+, Ca2+, Cl-) and cellular localisation (plasma membrane, ER, mitochondria).

There are hundreds of channel types encoded by many genes (e.g. >300 channel types and >500 genes for subunits).

🌊 Major channel families

• Potassium channels (K): Kv (6TM) for repolarisation, Kir (2TM) inward rectifiers for resting potential, and two-pore (4TM) leak channels.
• Sodium channels (Na): Voltage-gated Nav are formed from a single large α subunit with four homologous domains (each with 6TM segments). Responsible for AP initiation and propagation.
• Calcium channels (Ca): VOCCs (L-, N-, P/Q-, R-, T-types) mediate Ca2+ influx for contraction, secretion and neurotransmitter release. Store-operated and intracellular channels (IP3R, RyR) control ER/SR Ca2+.
• Chloride channels (Cl): include CFTR and other channels; Cl- is the major physiological anion.
• Transient Receptor Potential (TRP) channels: diverse non-selective cation channels implicated in sensory transduction (pain, temperature, taste).

🧩 Structural notes

Voltage-gated Na+ channels: large α subunit with 4 repeated domains (I–IV), each domain containing 6 transmembrane segments. Ligand-gated pentameric channels (e.g. nAChR) have multiple subunits and two ligand binding sites; opening gates are composed of four transmembrane helices per subunit.

💊 Pharmacology & toxins

• Na+ channel blockers: tetrodotoxin (TTX), saxitoxin, local anaesthetics (e.g. lidocaine) block conduction; some toxins block inactivation (e.g. veratridine).
• nAChR ligands: agonists (nicotine), antagonists (curare, tubocurarine, pancuronium), depolarising blockers (suxamethonium).
• K+ channel modulators: openers (pinacidil, minoxidil — vasodilators), blockers (sulphonylureas block KATP to stimulate insulin release; TEA and 4-AP block Kv channels).
• Ca2+ channel blockers: verapamil, amlodipine — reduce cardiac and smooth muscle Ca2+ entry and lower blood pressure.
• TRPV1: agonist capsaicin; antagonists include capsazepine and NGX-4010.

Many toxins (e.g. dendrotoxins, conotoxins, scorpion toxins) act selectively on channel subtypes and are valuable pharmacological tools.

🦠 Channelopathies

Mutations in channel genes cause channelopathies affecting neuronal, cardiac and endocrine systems. Examples include arrhythmias, neonatal diabetes (KATP mutations), and some neurodegenerative or excitability disorders. Genetic diversity (many genes encoding channel subunits) explains the range of clinical phenotypes.

📍 Localisation of channels

• Plasma membrane: Nav, Kv, Cav, ClC family.
• Endoplasmic/Sarcoplasmic reticulum: RyR, IP3R (intracellular Ca2+ release channels).
• Mitochondria: examples include mitochondrial KATP channels.

📚 Further reading

Recommended texts: Rang & Dale's Pharmacology (Ion channels as drug targets) and focused reviews on channel structure, TRP biology and clinical channelopathies for deeper study.